3191eP Development of an EORTC strategy to measure health-related quality of life in cancer patients receiving immune checkpoint inhibitors: Phase I and II.
Saved in:
| Title: | 3191eP Development of an EORTC strategy to measure health-related quality of life in cancer patients receiving immune checkpoint inhibitors: Phase I and II. |
|---|---|
| Authors: | Fox, L.1 (AUTHOR), Egeler, M.2 (AUTHOR), Singer, S.3 (AUTHOR), Brédart, A.4 (AUTHOR), Kiyota, N.5 (AUTHOR), Saad, A.6 (AUTHOR), Abaza, H.7 (AUTHOR), De Padova, S.8 (AUTHOR), Lee, R.J.9 (AUTHOR), Wu, Y.10 (AUTHOR), Lai-Kwon, J.E.11 (AUTHOR), Enting, D.12 (AUTHOR), Bonilla, S.A.Z.13 (AUTHOR), Abdel-Razeq, H.7 (AUTHOR), Matsumoto, S.5 (AUTHOR), van Leeuwen, M.2 (AUTHOR), Van Hemelrijck, M.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS695-S695. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
